Newsmeme!
Discover News you didn't know existed
Ophthalmic
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Skipping care might not be best medicine
Published July 6, 2009, 3:22 am, The Columbus Dispatch
Maybe the headache will go away. Maybe that painful twisted ankle is healing on its own. Maybe that blood sugar isn't that high after all.
Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle ...
Published July 5, 2009, 9:01 pm, PR Newswire via Yahoo! Finance
Coapt Systems, Inc. announced the launch of Hydrelle a new, FDA-approved hyaluronic acid based dermal filler for the treatment of facial wrinkles, such as nasolabial folds, also called "smile lines."
No rest for crew as they restore carrier Carl Vinson
Published July 5, 2009, 8:46 pm, The Virginian-Pilot
NORFOLK Question: What's harder than building an aircraft carrier from scratch? Answer: Rebuilding one from the frame up after a quarter-century of constant, punishing use. After 43 months at the shipyard in Newport News for its refueling and complex overhaul, the Carl Vinson is nearly ready to re-enter service.
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
Published July 5, 2009, 8:14 pm, redOrbit
EMERYVILLE, Calif. and HUENENBERG, Switzerland, July 5 /PRNewswire-FirstCall/ -- Alcon, Inc. (NYSE: ACL) and its partner, NovaBay Pharmaceuticals, Inc.
Alcon Commences Phase 2 Clinical Trial of NovaBays NVC-422 for Viral Conjunctivitis
Published July 5, 2009, 3:14 pm, Finanzen.net
Alcon, Inc. (NYSE: ACL ) ...
Lasik lawsuits: Disciplinary proceedings lag against Chicago doctor
Published July 5, 2009, 3:11 pm, Chicago Tribune
TRIBUNE WATCHDOG: State lets Dr. Nicholas Caro practice despite lawsuits, more than $1 million in damages Karen Thiel just wanted to see well without wearing contact lenses.
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
Published July 5, 2009, 3:00 pm, PR Newswire via Yahoo! Finance
Alcon, Inc. and its partner, NovaBay Pharmaceuticals, Inc. , announced today that Alcon has begun treating patients in a Phase 2 clinical trial of NovaBay's patented lead Aganocide® compound, NVC-422, for viral conjunctivitis, a type of "pink eye".
People on the move
Published July 5, 2009, 8:11 am, Pensacola News Journal
Francisca Lowe has joined the staff of Trend's Salon Spa. Lowe has 30 years of experience as an esthetician. She received her training in South America; in Atlanta at the International Dermal Institute (Dermalogica); and by the Aveda, Pevonia, Skin Ceuticials and the Esthetic Association.
Convicted ophthalmology swindler receives 40-month federal sentence
Published July 5, 2009, 1:22 am, North Penn Life
A Doylestown woman convicted of stealing at least $783,000 from an ophthalmology practice in Lansdale received a 40-month prison sentence in federal court Thursday, according to the U.S. Attorney’s Office in Philadelphia.
Despite suits, state lets eye doctor practice
Published July 4, 2009, 8:21 am, Chicago Tribune
Tribune Watchdog: The state has let eye doctor Nicholas Caro continue practicing despite lawsuits resulting in more than $1 million in damages and Illinois' chief medical prosecutor's recommendation his license be revoked.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |